John Boockvar, M.D.

I am a fourth generation physician who understands that physician availability and excellent bedside manner are extremely important to helping my patients heal from their disease. I strive to provide my patients with the best level of care, at an affordable cost. I understand that in this difficult time in health care, stress levels are extremely high in our patient population. I will do everything possible to help ensure that my patient's experience includes the best level of surgical care, using the most modern technological approach. Equally as important, I will do all I can to help my patient and their family to navigate the pre and post operative course with empathy and support to aide in the healing process.

John Boockvar, MD, is a board-certified adult neurosurgeon. Dr. Boockvar received a B.A. and graduated Cum Laude from the University of Pennsylvania. Dr. Boockvar received an M.D. from SUNY Brooklyn-Downstate Medical Center where he graduated Summa Cum Laude with Distinction in Research and was medical school class valedictorian. Dr. Boockvar did his surgical internship and neurosurgical residency at the Hospital of the University of Pennsylvania. Dr. Boockvar did specialized NIH/National Cancer Institute supported fellowship training in Neuro-oncology (Brain and Spinal Tumors) at the University of Pennsylvania Cancer Center. Dr. Boockvar has surgical expertise in treating brain and spinal disorders.

Dr. Boockvar's surgical focus is in benign and malignant brain and spinal tumors, skull base and endoscopic pituitary surgery, peripheral nerve tumors, minimally invasive spinal surgery and complex spinal disorders. Dr. Boockvar performs minimally invasive brain and spinal neurosurgery. Dr. Boockvar recently published the largest series to date on minimally invasive microdiscectomy for lumbar herniated discs. For this reference go to http://thejns.org/doi/pdf/10.3171/2009.12.SPINE08843. Click on the publications tab above to see more publications.

Dr. Boockvar currently is Co-Director of the Brain and Spinal Tumor Program at Weill Cornell Medical College and is Co-Director of Surgical Neurooncology at Weill Cornell. Dr. Boockvar heads the Brain Tumor and Stem Cell Research Laboratory and directs the institution's Brain Tumor Research Group. Dr. Boockvar's laboratory interests have focused on studying brain tumor formation and brain tumor and stem cell survival. Dr. Boockvar has a particular interest in improving how drugs are delivered to the brain and spinal cord. Dr. Boockvar's laboratory is funded by the National Cancer Institute. Dr. Boockvar served as Editor-in-Chief of the journal Current Stem Cell Research and Therapy and is an editorial board member of the Journal of Neuro-Oncology, Journal of Neurosurgery, and Recent Patents on Anti-Cancer Drug Discovery. He is an ad-hoc reviewer for Neurosurgery, Brain Research and Human Gene Therapy. He is a member of the Executive Committee (2009-2011) of the Joint Section of Brain Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons and was recently appointed to the Editorial Board of the Journal of Neurooncology. He also serves as a Scientific Program Committee member for the Society of Neurooncology. Dr. Boockvar is the principal investigator of several new exciting clinical trials using super selective intraarterial infusion techniques for the delivery of novel therapeutics such as Temodar, Avastin or Cetuximab for the treatment of malignant brain cancer. He recently was given approval by the FDA to start a novel clinical trial for patients with Acoustic Schwannoma (vestibular schwannoma). For more information on these trials please visit ClinicalTrials.Gov or call 212-746-1996 or email Dr. Boockvar jab2029@nyp.org.

Dr. Boockvar has been highlighted in multiple newspapers (New York Times, Daily News, Wall Street Journal, Crain's) and on television (ABC, CNN, Fox News, CNBC, MSNBC, Dr. Oz show) for his treatment of brain and spinal tumors and for his minimally invasive surgical approaches to the brain and spine. Dr. Boockvar has published multiple articles on the subjects of brain and spinal neurosurgery. Dr. Boockvar has been chosen as one of America's Top Doctors (2009-2011), America's Top Surgeons (2009-2011) and as a Top Doctor in the New York Metro Area (2011-2012). Most recently he was seen in the New York Times, on CNBC and CBS Evening News for his work on a novel treatment for brain tumors using Super Selective Delivery of Targeted Therapies. On November 9, 2010, the anniversary issue of the New York Times Science Times asked science reporters and top researchers to provide their watch list for noteworthy advances in 2011 and to identify which "fields are hot". This list included Dr. Boockvar and the studies he is conducting for people with Glioblastoma Multiforme. Dr. Boockvar was most recently seen on Dr. Oz in a special segment on Brain Cancer (see episode at http://www.doctoroz.com/videos/your-headache-cancer-pt-1 and http://www.doctoroz.com/videos/your-headache-cancer-pt-2).

Dr. Boockvar's father, grandfather and great-grandfather were all physicians, so he understands the importance of the physician-patient relationship. He has been recognized for the exceptional quality of care that he provides to his patients. He was awarded the 2009 Platinum Service Excellence Award for outstanding customer service to his patients. In addition, he was awarded the 2009 Employee of the Year Award for the Department of Neurosurgery. He currently sits on the Quality Assurance Committee and the Patient Safety Committee for New York Presbyterian Hospital/Weill Cornell Medical Center as well as the Institutional Medical Malpractice Claims Committee. In addition, he was the faculty "Superchampion" of the EPIC optimization committee to enhance the electronic medical record (EMR) at New York Presbyterian/Weill Cornell Medical Center. Dr. Boockvar is hosting the first Brain Tumor Biotech Summit on June 8, 2012. This is an interactive symposium designed to bring together leading cancer researchers and the investment community to facilitate better treatments for patients with brain tumors. For more information please visit www.cornellneurosurgery/braintumor or www.braintumorbiotechsummit.org.